Skip to main content
Log in

5-(1,3-Benzothiazol-2-yl)furan-2-carbaldehyde in the Design of Antitumor Agents

  • Published:
Russian Journal of Organic Chemistry Aims and scope Submit manuscript

Abstract

Reactions of 5-(1,3-benzothiazol-2-yl)furan-2-carbaldehyde with 2-acetylfuran, 2-acetylthiophene, and some compounds containing an active methylene group gave a number of new 3-[5-(1,3-benzothiazol-2-yl)furan-2-yl]-1-(furan- or thiophen-2-yl)prop-2-en-1-one, 3-[5-(1,3-benzothiazol-2-yl)furan-2-yl]acrylonitrile, 3-[5-(1,3-benzothiazol-2-yl)furan-2-yl]-2-cyanoacrylamide, and 5-{[5-(1,3-benzothiazol-2-yl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one derivatives. 5-{[5-(1,3-Benzothiazol-2-yl)furan-2-yl]methylidene}-2-(morpholin-4-yl)-1,3-thiazol-4-one and diethyl 4-[5-(1,3-benzothiazol-2-yl)furan-2-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate were synthesized by multicomponent reactions involving the title compound. Antitumor screening of the synthesized 5-(1,3-benzothiazol-2-yl)furan-2-carbaldehyde derivatives revealed a lead compound, 3-[5-(1,3-benzothiazol-2-yl)furan-2-yl]-2-(4-phenyl-1,3-thiazol-2-yl)prop-2-enenitrile, which proved to be superior to 5-fluorouracil, cisplatin, and curcumin taken as reference drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme
Scheme
Scheme

Similar content being viewed by others

REFERENCES

  1. Tariq, S., Kamboj, P., and Amir, M., Arch. Pharm., 2018, vol. 352, article ID e1800170. https://doi.org/10.1002/ardp.201800170

  2. Irfan, A., Batool, F., Zahra Naqvi, S.A., Islam, A., Osman, S.M., Nocentini, A., Alissa, S.A., and Supuran, C.T., J. Enzyme Inhib. Med. Chem., 2020, vol. 35, p. 265. https://doi.org/10.1080/14756366.2019.1698036

    Article  CAS  PubMed  Google Scholar 

  3. Gao, X., Liu, J., Zuo, X., Feng, X., and Gao, Y., Molecules, 2020, vol. 25, p. 1675. https://doi.org/10.3390/molecules25071675.

    Article  CAS  PubMed Central  Google Scholar 

  4. Jain, S., Pattnaik, S., Pathak, K., Kumar, S., Pathak, D., Jain, S., and Vaidya, A., Mini Rev. Med. Chem., 2018, vol. 18, p. 640. https://doi.org/10.2174/1389557517666171123211321

    Article  CAS  PubMed  Google Scholar 

  5. Pathak, N., Rathi, E., Kumar, N., Kini, S.G., and Rao, C.M., Mini Rev. Med. Chem., 2020, vol. 20, p. 12. https://doi.org/10.2174/1389557519666190617153213

    Article  CAS  PubMed  Google Scholar 

  6. Eshkil, F., Eshghi, H., Saljooghi, A.S., Bakavoli, M., and Rahimizadeh, M., Russ. J. Bioorg. Chem., 2017, vol. 43, p. 576. https://doi.org/10.1134/S1068162017050065

    Article  CAS  Google Scholar 

  7. Singh, M., Modi, A., Narayan, G., and Singh, S.K., Anticancer Drugs, 2016, vol. 27, p. 519. https://doi.org/10.1097/CAD.0000000000000357

    Article  CAS  PubMed  Google Scholar 

  8. Hutchinson, I., Jennings, S.A., Vishnuvajjala, B.R., Westwell, A.D., and Stevens, M.F., J. Med. Chem., 2002, vol. 45, p. 744. https://doi.org/10.1021/jm011025r

    Article  CAS  PubMed  Google Scholar 

  9. Horishny, V., Kartsev, V., Geronikaki, A., Matiychuk, V., Petrou, A., Glamoclija, J., Ciric, A., and Sokovic, M., Molecules, 2020, vol. 25, p. 1964. https://doi.org/10.3390/molecules25081964

    Article  CAS  PubMed Central  Google Scholar 

  10. Obushak, N.D., Gorak, Yu.I., Matiichuk, V.S., and Lytvyn, R.Z., Russ. J. Org. Chem., 2008, vol. 44, p. 1689. https://doi.org/10.1134/S1070428008110213

    Article  CAS  Google Scholar 

  11. Pokhodylo, N.T., Matiychuk, V.S., and Obushak, N.D., Chem. Heterocycl. Compd., 2009, vol. 45, p. 483. https://doi.org/10.1007/s10593-009-0287-6

    Article  CAS  Google Scholar 

  12. Tsyalkovsky, V.M., Kutsyk, R.V., Matiychuk, V.S., Obushak, N.D., and Klyufinskaya, T.I., Pharm. Chem. J., 2005, vol. 39, p. 245. https://doi.org/10.1007/s11094-005-0126-8

    Article  CAS  Google Scholar 

  13. Pokhodylo, N.T. and Matiychuk, V.S., J. Heterocycl. Chem., 2010, vol. 47, p. 415. https://doi.org/10.1002/jhet.321

    Article  CAS  Google Scholar 

  14. Pokhodylo, N.T., Matiychuk, V.S., and Obushak, M.D., Synthesis, 2009, vol. 2009, no. 8, p. 1297. https://doi.org/10.1055/s-0028-1087992

    Article  CAS  Google Scholar 

  15. Pokhodylo, N.T., Teslenko, Y.O., Matiychuk, V.S., and Obushak, M.D., Synthesis, 2009, vol. 2009, no. 16, p. 2741. https://doi.org/10.1055/s-0029-1216875

    Article  CAS  Google Scholar 

  16. Pokhodylo, N.T., Matiychuk, V.S., and Obushak, N.D., Chem. Heterocycl. Compd., 2009, vol. 45, p. 121. https://doi.org/10.1007/s10593-009-0238-2

    Article  CAS  Google Scholar 

  17. Obushak, M.D., Matiychuk, V.S., and Lytvyn, R.Z., Chem. Heterocycl. Compd., 2008, vol. 44, p. 936. https://doi.org/10.1007/s10593-008-0135-0

    Article  CAS  Google Scholar 

  18. Chaban, T.I., Ogurtsov, V.V., Matiychuk, V.S., Chaban, I.G., Demchuk, I.L., and Nektegayev, I.A., Acta Chim. Slov., 2019, vol. 66, p. 103. https://doi.org/10.17344/acsi.2018.4570

    Article  CAS  Google Scholar 

  19. Obushak, M.D., Matiychuk, V.S., and Turytsya, V.V., Tetrahedron Lett., 2009, vol. 50, p. 6112. https://doi.org/10.1016/j.tetlet.2009.08.024

    Article  CAS  Google Scholar 

  20. Pokhodylo, N.T., Shyyka, O.Y., Matiychuk, V.S., and Obushak, M.D., ACS Comb. Sci., 2015, vol. 17, p. 399. https://doi.org/10.1021/co5001376

    Article  CAS  PubMed  Google Scholar 

  21. Tymoshuk, O.S., Fedyshyn, O.S., Oleksiv, L.V., Rydchuk, P.V., and Matiychuk, V.S., J. Chem., 2020, vol. 2020, article ID 8141853. https://doi.org/10.1155/2020/8141853

  22. Bazel, Y., Tupys, A., Ostapiuk, Y., Tymoshuk, O., and Matiychuk, V., J. Mol. Liq., 2017, vol. 242, p. 471. https://doi.org/10.1016/j.molliq.2017.07.047

    Article  CAS  Google Scholar 

  23. Tupys, A., Kalembkiewicz, J., Ostapiuk, Y., Matiichuk, V., Tymoshuk, O., Woźnicka, E., and Byczyński, Ł., J. Therm. Anal. Calorim., 2017, vol. 127, p. 2233. https://doi.org/10.1007/s10973-016-5784-0

    Article  CAS  Google Scholar 

  24. Lozyns’ka, L.V., Tymoshuk, O.S., and Vrublevs’ka, T.Y., Mater. Sci., 2015, vol. 50, p. 870. https://doi.org/10.1007/s11003-015-9795-y

    Article  CAS  Google Scholar 

  25. Lozynska, L. and Tymoshuk, O., Chem. Chem. Technol., 2013, vol. 7, p. 391. https://doi.org/10.23939/chcht07.04.391

    Article  CAS  Google Scholar 

  26. Tupys, A., Tymoshuk, O., and Rydchuk, P., Chem. Chem. Technol., 2016, vol. 10, p. 19. https://doi.org/10.23939/chcht10.01.019

    Article  CAS  Google Scholar 

  27. Paizs, C., Toșa, M.I., Majdik, C., Taehtinen, P., Irimie, F.D., and Kanerva, L.T., Tetrahedron: Asymmetry, 2003, vol. 14, p. 619. https://doi.org/10.1016/S0957-4166(03)00025-9

    Article  CAS  Google Scholar 

  28. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., and Boyd, M., J. Natl. Cancer Inst., 1991, vol. 83, p. 757. https://doi.org/10.1093/jnci/83.11.757

    Article  CAS  PubMed  Google Scholar 

  29. Boyd, M.R. and Paull, K.D., Drug Dev. Res., 1995, vol. 34, p. 91. https://doi.org/10.1002/ddr.430340203

    Article  CAS  Google Scholar 

  30. Boyd, M.R., Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Teicher, B.A., Ed., Totowa: Humana Press, 1997, p. 23.

  31. Shoemaker, R.H., Nat. Rev. Cancer, 2006, vol. 6, p. 813. https://doi.org/10.1038/nrc1951

    Article  CAS  PubMed  Google Scholar 

  32. Rostom, S.A., Bioorg. Med. Chem., 2006. vol. 14, p. 6475. https://doi.org/10.1016/j.bmc.2006.06.020

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. S. Matiychuk.

Ethics declarations

The authors declare the absence of conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matiichuk, Y.E., Horak, Y.I., Chaban, T.I. et al. 5-(1,3-Benzothiazol-2-yl)furan-2-carbaldehyde in the Design of Antitumor Agents. Russ J Org Chem 56, 1720–1727 (2020). https://doi.org/10.1134/S1070428020100085

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1070428020100085

Keywords:

Navigation